4/8
08:03 am
mplt
Maplight Therapeutics (MPLT) is now covered by Needham & Company LLC. They set a "buy" rating and a $37.00 price target on the stock.
Medium
Report
Maplight Therapeutics (MPLT) is now covered by Needham & Company LLC. They set a "buy" rating and a $37.00 price target on the stock.
4/7
09:00 am
mplt
Maplight Therapeutics (MPLT) is now covered by TD Cowen. They set a "buy" rating on the stock.
Medium
Report
Maplight Therapeutics (MPLT) is now covered by TD Cowen. They set a "buy" rating on the stock.
3/26
07:51 am
mplt
MapLight Therapeutics, Inc. GAAP EPS of -$2.47 [Seeking Alpha]
Low
Report
MapLight Therapeutics, Inc. GAAP EPS of -$2.47 [Seeking Alpha]
3/26
07:00 am
mplt
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Medium
Report
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
3/21
01:31 am
mplt
Low
Report
3/19
09:00 am
mplt
Maplight Therapeutics (MPLT) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $35.00 price target on the stock.
Low
Report
Maplight Therapeutics (MPLT) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $35.00 price target on the stock.
3/2
07:35 am
mplt
MapLight Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
MapLight Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
3/2
07:00 am
mplt
MapLight Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
MapLight Therapeutics to Participate in Upcoming Investor Conferences
4/17
04:05 pm
mplt
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: GILLIS JONATHAN
Neutral
Report
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: GILLIS JONATHAN
4/17
04:05 pm
mplt
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Setia Vishwas
Neutral
Report
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Setia Vishwas
4/17
04:05 pm
mplt
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Kreitzer Anatol
Neutral
Report
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Kreitzer Anatol
4/17
04:05 pm
mplt
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Foff Erin Pennock
Neutral
Report
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Foff Erin Pennock
4/17
04:05 pm
mplt
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Lillie James Woodruff
Neutral
Report
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Lillie James Woodruff
4/17
04:05 pm
mplt
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Hanson Kristopher
Neutral
Report
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Hanson Kristopher
4/17
04:05 pm
mplt
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Kroeger Christopher A.
Neutral
Report
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Kroeger Christopher A.
4/17
04:05 pm
mplt
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Malenka Robert C.
Neutral
Report
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Malenka Robert C.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register